ICU Net Working Capital from 2010 to 2026

ICUI Stock  USD 144.90  2.88  2.03%   
ICU Medical's Net Working Capital is increasing with slightly volatile movements from year to year. Net Working Capital is predicted to flatten to about 809.3 M. For the period between 2010 and 2026, ICU Medical, Net Working Capital quarterly trend regression had mean deviation of  80,670,541 and range of 384.9 M. View All Fundamentals
 
Net Working Capital  
First Reported
2020-03-31
Previous Quarter
697.3 M
Current Value
714.4 M
Quarterly Volatility
60.7 M
 
Covid
 
Interest Hikes
Check ICU Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICU Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.7 M, Interest Expense of 128.6 M or Total Revenue of 2.9 B, as well as many indicators such as Price To Sales Ratio of 1.74, Dividend Yield of 0.0 or PTB Ratio of 3.58. ICU financial statements analysis is a perfect complement when working with ICU Medical Valuation or Volatility modules.
  
Build AI portfolio with ICU Stock
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.
The Net Working Capital trend for ICU Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether ICU Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest ICU Medical's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of ICU Medical over the last few years. It is ICU Medical's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

ICU Net Working Capital Regression Statistics

Arithmetic Mean723,213,560
Geometric Mean716,690,833
Coefficient Of Variation14.70
Mean Deviation80,670,541
Median654,370,000
Standard Deviation106,332,226
Sample Variance11306.5T
Range384.9M
R-Value0.77
Mean Square Error4955.7T
R-Squared0.59
Significance0.0003
Slope16,161,637
Total Sum of Squares180904.7T

ICU Net Working Capital History

2026809.3 M
2025B
2024885.8 M
2023739.4 M
2022740.6 M
2021829 M
2020725.3 M

About ICU Medical Financial Statements

Investors use fundamental indicators, such as ICU Medical's Net Working Capital, to determine how well the company is positioned to perform in the future. Although ICU Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Working CapitalB809.3 M

Currently Active Assets on Macroaxis

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is there potential for Health Care Equipment & Supplies market expansion? Will ICU introduce new products? Factors like these will boost the valuation of ICU Medical. Market participants price ICU higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Earnings Share
(0.32)
Revenue Per Share
94.357
Quarterly Revenue Growth
(0.09)
Return On Assets
0.0192
ICU Medical's market price often diverges from its book value, the accounting figure shown on ICU's balance sheet. Smart investors calculate ICU Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since ICU Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.